Mehmet A Bilen - JoVE Visualize

Showing results (31-40 of 136) with videos related to

Pageof 14

Sort By:

Cancer|April 30, 2009

Ductal adenocarcinoma of the prostate: clinical features and implications after local therapyShi-Ming Tu, Adriana Lopez, Dan Leibovici, et al.

Urology|January 31, 2026

Homologous recombination repair mutations, next-generation sequencing testing, and treatment progression by race among patients with metastatic castration-sensitive prostate cancerMehmet A Bilen, Neal Shore, Sabree Burbage, et al.

Cancer Research|June 15, 2011

BMP4 promotes prostate tumor growth in bone through osteogenesisYu-Chen Lee, Chien-Jui Cheng, Mehmet A Bilen, et al.

European Urology Oncology|April 30, 2025

Cabozantinib plus Pembrolizumab as First-line Therapy for Cisplatin-ineligible Advanced Urothelial Carcinoma: The PemCab TrialRohit K Jain, Umang Swami, Mehmet A Bilen, et al.

Frontiers in Oncology|February 18, 2021

Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case ReportMehmet A Bilen, James F Jiang, Caroline S Jansen, et al.

The Journal of Pathology|March 2, 2010

Androgen depletion up-regulates cadherin-11 expression in prostate cancerYu-Chen Lee, Chien-Jui Cheng, Miao Huang, et al.

Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|January 8, 2019

MRI quantitation of abdominal skeletal muscle correlates with CT-based analysis: implications for sarcopenia measurementAmir Ishaq Khan, David A Reiter, Aarti Sekhar, et al.

Journal of Visualized Experiments : Jove|April 5, 2021

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and HorosSean Steele, Fangyi Lin, Thien-Linh Le, et al.

Cancer|January 6, 2023

Race-free renal function estimation equations and potential impact on Black patients: Implications for cancer clinical trial enrollmentBenjamin N Schmeusser, Arnold R Palacios, Eric R Midenberg, et al.

Frontiers in Oncology|November 16, 2020

Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional CohortPedro Barata, Whitley Hatton, Arpita Desai, et al.

Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:

Pageof 14

Cancer|April 30, 2009

Ductal adenocarcinoma of the prostate: clinical features and implications after local therapyShi-Ming Tu, Adriana Lopez, Dan Leibovici, et al.

Urology|January 31, 2026

Homologous recombination repair mutations, next-generation sequencing testing, and treatment progression by race among patients with metastatic castration-sensitive prostate cancerMehmet A Bilen, Neal Shore, Sabree Burbage, et al.

Cancer Research|June 15, 2011

BMP4 promotes prostate tumor growth in bone through osteogenesisYu-Chen Lee, Chien-Jui Cheng, Mehmet A Bilen, et al.

European Urology Oncology|April 30, 2025

Cabozantinib plus Pembrolizumab as First-line Therapy for Cisplatin-ineligible Advanced Urothelial Carcinoma: The PemCab TrialRohit K Jain, Umang Swami, Mehmet A Bilen, et al.

Frontiers in Oncology|February 18, 2021

Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case ReportMehmet A Bilen, James F Jiang, Caroline S Jansen, et al.

The Journal of Pathology|March 2, 2010

Androgen depletion up-regulates cadherin-11 expression in prostate cancerYu-Chen Lee, Chien-Jui Cheng, Miao Huang, et al.

Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|January 8, 2019

MRI quantitation of abdominal skeletal muscle correlates with CT-based analysis: implications for sarcopenia measurementAmir Ishaq Khan, David A Reiter, Aarti Sekhar, et al.

Journal of Visualized Experiments : Jove|April 5, 2021

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and HorosSean Steele, Fangyi Lin, Thien-Linh Le, et al.

Cancer|January 6, 2023

Race-free renal function estimation equations and potential impact on Black patients: Implications for cancer clinical trial enrollmentBenjamin N Schmeusser, Arnold R Palacios, Eric R Midenberg, et al.

Frontiers in Oncology|November 16, 2020

Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional CohortPedro Barata, Whitley Hatton, Arpita Desai, et al.

Pageof 14